@MECFSNews I agree & think the story is more complex than simply GPCR-AAb’s....However, I wouldn’t discount them on the basis of the RituxME trial. In this nephrology study almost 1/4 of all patients had anti-rituximab antibodies at 6/12. https://
https://t.co/ooedyBQ1Er Rituximab treatment for membranous nephropathy (autoimmune disease) itself leads to neutralising AAb’s to rituximab. Question: Does this occour in other autoimmune conditions where rituximab is used?
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab https://t.co/OvjBaGWttY
RT @abdelhamed012: Frontiers | Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab | Immuno…